News

Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced the…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Neogene Therapeutics, Inc., a…
Read More...

HITGEN announces it has entered into a definitive agreement with Ligand Pharmaceuticals Inc. to acquire Vernalis (R&D) Limited, Cambridge, UK-based world leaders in fragment and…
Read More...

Astellas Pharma Inc. and Seagen Inc. announced positive topline results from the second cohort of patients in the pivotal phase 2 single-arm clinical trial known as EV-201. The cohort…
Read More...

Axis Therapeutics Limited, a joint venture between Athenex, Inc. and Xiangxue Life Sciences Limited, focused on the research, development, and commercialization of T cell immunotherapy,…
Read More...

CStone Pharmaceuticals announced the completion of the Share Subscription Agreement through which an affiliate of Pfizer Inc. subscribed for newly issued CStone shares at approximately…
Read More...

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces that it received investigational new drug application (IND) approval from FDA for its drug candidate…
Read More...

As the number of COVID-19 cases and deaths continues to rise in most countries, Australian clinical-stage drug development company Noxopharm is pleased to announce treatment of the…
Read More...

Qualigen Therapeutics, Inc. announces it has entered into an agreement with Yi Xin Zhen Duan Jishu (Suzhou) Ltd, of Suzhou, China to develop, manufacture and sell new generations of…
Read More...

Johnson & Johnson announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen…
Read More...

Takeda Pharmaceutical Company Limited and Arrowhead Pharmaceuticals Inc. announced a collaboration and licensing agreement to develop ARO-AAT, a Phase 2 investigational RNA interference…
Read More...

Pfizer Inc. and Sangamo Therapeutics, Inc. a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE study of giroctocogene…
Read More...

OliX Pharmaceuticals announced a collaboration with Théa Open Innovation, a sister company of Laboratoires Théa S.A.S ("Théa"), the leading independent pharmaceutical company in Europe …
Read More...

Citius Pharmaceuticals, Inc. a specialty pharmaceutical company developing and commercializing critical care drug products, announced that it has signed an exclusive agreement with…
Read More...

Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to Care Early) study…
Read More...

Oragenics, Inc. announced receipt of feedback to its Type B Pre-IND Meeting Request from the U.S. Food and Drug Administration (“FDA”) that it is in broad agreement with the Company’s…
Read More...

Pfizer Inc. and BioNTech SE announced the initiation of a rolling submission to the European Medicines Agency (EMA) for BNT162b2, the lead candidate from the companies’ vaccine…
Read More...

Aro Biotherapeutics, a biotechnology company focused on developing a new generation of medicines based on its proprietary CENTYRIN technology, announced that Ionis Pharmaceuticals,…
Read More...

Scribe Therapeutics Inc., the company focused on engineering the most advanced platform for CRISPR-based genetic medicine, announced a research collaboration with Biogen Inc. to develop…
Read More...